Cubist Systematic Strategies, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,718,713
-3.8%
63,964
+27.7%
0.01%
+8.3%
Q2 2023$1,786,031
-19.0%
50,085
-7.9%
0.01%
-7.7%
Q4 2022$2,205,815
+189.5%
54,384
+135.8%
0.01%
+225.0%
Q3 2022$762,000
-62.3%
23,063
-59.8%
0.00%
-66.7%
Q2 2022$2,020,000
-60.5%
57,380
-48.4%
0.01%
-72.1%
Q1 2022$5,119,000
+212.5%
111,303
+350.5%
0.04%
+168.8%
Q4 2021$1,638,000
+304.4%
24,709
+280.8%
0.02%
+220.0%
Q3 2021$405,000
-92.3%
6,489
-89.8%
0.01%
-91.5%
Q2 2021$5,276,000
+98.4%
63,703
+58.9%
0.06%
+73.5%
Q1 2021$2,659,000
+522.7%
40,092
+619.7%
0.03%
+466.7%
Q4 2020$427,000
-22.5%
5,571
-56.5%
0.01%
-25.0%
Q3 2020$551,000
+56.5%
12,806
+57.1%
0.01%
+33.3%
Q2 2020$352,000
-32.4%
8,154
-55.0%
0.01%
-57.1%
Q1 2020$521,000
-80.4%
18,118
-56.7%
0.01%
-71.4%
Q4 2019$2,654,000
+182.6%
41,849
+25.7%
0.05%
+157.9%
Q3 2019$939,000
-26.3%
33,306
-30.7%
0.02%
-17.4%
Q2 2019$1,274,000
+359.9%
48,062
+218.2%
0.02%
+155.6%
Q1 2019$277,000
+15.4%
15,104
-21.7%
0.01%
-18.2%
Q4 2018$240,000
-1.6%
19,289
+7.5%
0.01%
-8.3%
Q2 2018$244,000
+771.4%
17,941
+365.6%
0.01%
+500.0%
Q3 2016$28,000
+3.7%
3,853
-23.3%
0.00%0.0%
Q2 2016$27,0005,0240.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders